Dexamethasone Therapy in VLBW Infants at Risk of CLD
Status:
Completed
Trial end date:
1994-04-01
Target enrollment:
Participant gender:
Summary
Infants who are on breathing support are often treated with steroids (dexamethasone);
however, the best timing of therapy is not known. This trial looked at the benefits and
hazards of starting dexamethasone therapy at two weeks of age and four weeks of age in
premature infants.